Minitran Information
What's inside Minitran
Minitran Active Ingredients: nitroglycerin, details.| Minitran Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Minitran 0.2 mg/hr | film, extended release | transdermal | 1.0 hour(s) | OTC |
| Minitran 0.4 mg/hr | film, extended release | transdermal | 1.0 hour(s) | OTC |
| Minitran 0.6 mg/hr | film, extended release | transdermal | 1.0 hour(s) | OTC |
| Minitran 0.1 mg/hr | film, extended release | transdermal | 1.0 hour(s) | OTC |
Minitran in the News
Meda AB (publ.) - Q1 2007 Interim Report, January-March - American Digital Networks (press release)
Acquisition of 3M's pharma division in Europe means that Meda reached a new sales level, particularly due to addition of the Tambocor, Minitran and Aldara ...
Thu May 03 00:10:16 -0400 2007
Minitran Chemical Information
nitroglycerin - An organic nitrate with vasodilator activity. Nitroglycerin is converted into nitric oxide (NO) in smooth muscle and activates guanylyl cyclase, thereby increasing cGMP concentration, and resulting in smooth muscle relaxation. Dilatation of the veins results in decreased venous return to the heart, thereby decreasing left ventricular volume (reduced preload) and decreasing myocardial oxygen requirements. Arteriolar relaxation reduces arteriolar resistance (reduced afterload), thereby decreasing myocardial oxygen demands. In addition, nitroglycerine causes coronary artery dilatation, thereby improving myocardial blood distribution.
Minitran RSS Feed
